Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process-Reference-Cited by-同舟云学术

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Published:1998-01-01 Issue:1 Volume:91 Page:3-21
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Hallek Michael¹,Leif Bergsagel P.¹,Anderson Kenneth C.¹

Affiliation:

1. From Medizinische Klinik, Klinikum Innenstadt, and Genzentrum, Universität München, München, Germany; Cornell University Medical College, New York, NY; and Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/91/1/3/237091/3.pdf

Reference316 articles.

1. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity.;Vescio;J Immunol,1995

2. Interleukin-6 in human multiple myeloma.;Klein;Blood,1995

3. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.;Bakkus;Blood,1992

4. Non-random chromosomal aberrations associated with multiple myeloma.;Lewis;Hematol Oncol,1984

5. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.;Dewald;Blood,1985

Cited by 570 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy;Cancers;2024-01-06

2. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08

3. Insights into the relationship between persistent antibody secretion and metabolic programming – A question for single-cell analysis;Immunology Letters;2023-08

4. Methods for experimental monitoring of tissue vascularization;Medical alphabet;2023-01-13

5. Monoclonal gammopathy of undetermined significance (MGUS) characterized by refractory lower gastrointestinal postoperative bleeding with coagulopathy;Intractable & Rare Diseases Research;2022-11-30